A clinical randomized double-blind vehicle-controlled trial recruiting 63 type 2 diabetic patients with hypomagnesemia receiving glibenclamide has shown that supplementation of magnesium (2.5 g MgCl2/day) for 4 months improved HbA1c, fasting glucose as well as insulin levels[43]. This evidence concerns the gene INS and Hypomagnesemia.